Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy

por Hashiguchi, Yasunori, Kasai, Mari, Fukuda, Takeshi, Ichimura, Tomoyuki, Yasui, Tomoyo, Sumi, Toshiyuki
Publicado en Anticancer Drugs (2015)

UCP2 expression may represent a predictive marker of neoadjuvant chemotherapy effectiveness for locally advanced uterine cervical cancer

por Imai, Kenji, Fukuda, Takeshi, Wada, Takuma, Kawanishi, Masaru, Tasaka, Reiko, Yasui, Tomoyo, Sumi, Toshiyuki
Publicado en Oncol Lett (2017)

Metabolic and Morphologic Characteristics of Adipose Tissue Associated with the Growth of Malignant Tumors

por Ishiko, Osamu, Nishimura, Sadako, Yasui, Tomoyo, Sumi, Toshiyuki, Hirai, Kouzo, Honda, Ken‐ichi, Ogita, Sachio
Publicado en Jpn J Cancer Res (1999)

Minimal deviation mucinous adenocarcinoma of the uterine cervix that proved difficult to differentiate from endometrial cancer: A case report

por NISHII, YUKO, FUKUDA, TAKESHI, IMAI, KENJI, YAMAUCHI, MAKOTO, HASHIGUCHI, YASUNORI, ICHIMURA, TOMOYUKI, YASUI, TOMOYO, SUMI, TOSHIYUKI
Publicado 2014

Sirtuin1 expression predicts the efficacy of neoadjuvant chemotherapy for locally advanced uterine cervical cancer

por TERAMAE, MASATOMO, FUKUDA, TAKESHI, WADA, TAKUMA, KAWANISHI, MASARU, IMAI, KENJI, YAMAUCHI, MAKOTO, YASUI, TOMOYO, SUMI, TOSHIYUKI
Publicado en Mol Clin Oncol (2015)

Expression of epidermal growth factor-like domain 7 may be a predictive marker of the effect of neoadjuvant chemotherapy for locally advanced uterine cervical cancer

por Yamauchi, Makoto, Fukuda, Takeshi, Wada, Takuma, Kawanishi, Masaru, Imai, Kenji, Tasaka, Reiko, Yasui, Tomoyo, Sumi, Toshiyuki
Publicado en Oncol Lett (2016)

TBX2 expression is associated with platinum-sensitivity of ovarian serous carcinoma

por Tasaka, Reiko, Fukuda, Takeshi, Shimomura, Masahiro, Inoue, Yuta, Wada, Takuma, Kawanishi, Masaru, Yasui, Tomoyo, Sumi, Toshiyuki
Publicado en Oncol Lett (2018)

Expression of UCP2 is associated with sensitivity to platinum-based chemotherapy for ovarian serous carcinoma

por Kawanishi, Masaru, Fukuda, Takeshi, Shimomura, Masahiro, Inoue, Yuta, Wada, Takuma, Tasaka, Reiko, Yasui, Tomoyo, Sumi, Toshiyuki
Publicado en Oncol Lett (2018)

Mitotic arrest deficiency 2 induces carcinogenesis in mucinous ovarian tumors

por NAKANO, YUSUKE, SUMI, TOSHIYUKI, MORISHITA, MASANARI, FUKUDA, TAKESHI, NOBEYAMA, HIROYUKI, YOSHIDA, HIROYUKI, MATSUMOTO, YOSHINARI, YASUI, TOMOYO, ISHIKO, OSAMU
Publicado 2012

Comparison of outcomes between squamous cell carcinoma and adenocarcinoma in patients with surgically treated stage I–II cervical cancer

por YAMAUCHI, MAKOTO, FUKUDA, TAKESHI, WADA, TAKUMA, KAWANISHI, MASARU, IMAI, KENJI, HASHIGUCHI, YASUNORI, ICHIMURA, TOMOYUKI, YASUI, TOMOYO, SUMI, TOSHIYUKI
Publicado 2014

Complete recovery from paraneoplastic anti-NMDAR encephalitis associated with a small ovarian teratoma following a laparoscopic salpingo-oophorectomy: A case report

por IMAI, KENJI, FUKUDA, TAKESHI, WADA, TAKUMA, KAWANISHI, MASARU, YAMAUCHI, MAKOTO, HASHIGUCHI, YASUNORI, ICHIMURA, TOMOYUKI, YASUI, TOMOYO, SUMI, TOSHIYUKI
Publicado en Exp Ther Med (2015)

XPA expression is a predictive marker of the effectiveness of neoadjuvant chemotherapy for locally advanced uterine cervical cancer

por Wada, Takuma, Fukuda, Takeshi, Shimomura, Masahiro, Inoue, Yuta, Kawanishi, Masaru, Tasaka, Reiko, Yasui, Tomoyo, Ikeda, Kazuo, Sumi, Toshiyuki
Publicado en Oncol Lett (2018)

PRMT1 expression predicts response to neoadjuvant chemotherapy for locally advanced uterine cervical cancer

por Shimomura, Masahiro, Fukuda, Takeshi, Awazu, Yuichiro, Nanno, Shigenori, Inoue, Yuta, Matsubara, Hiroaki, Yamauchi, Makoto, Yasui, Tomoyo, Sumi, Toshiyuki
Publicado en Oncol Lett (2021)

PRMT1 expression predicts sensitivity to platinum-based chemotherapy in patients with ovarian serous carcinoma

por Matsubara, Hiroaki, Fukuda, Takeshi, Awazu, Yuichiro, Nanno, Shigenori, Shimomura, Masahiro, Inoue, Yuta, Yamauchi, Makoto, Yasui, Tomoyo, Sumi, Toshiyuki
Publicado en Oncol Lett (2021)

Expression of mitotic-arrest deficiency 2 predicts the efficacy of neoadjuvant chemotherapy for locally advanced uterine cervical cancer

por MORISHITA, MASANARI, SUMI, TOSHIYUKI, NAKANO, YUSUKE, TERAMAE, MASATOMO, FUKUDA, TAKESHI, NOBEYAMA, HIROYUKI, YOSHIDA, HIROYUKI, MATSUMOTO, YOSHINARI, YASUI, TOMOYO, ISHIKO, OSAMU
Publicado 2012

Pegylated liposomal doxorubicin for platinum-resistant or refractory Müllerian carcinoma (epithelial ovarian carcinoma, primary carcinoma of Fallopian tube and peritoneal carcinoma...

por FUKUDA, TAKESHI, SUMI, TOSHIYUKI, TERAMAE, MASATOMO, NAKANO, YUSUKE, MORISHITA, MASANARI, TERADA, HIROYUKI, YOSHIDA, HIROYUKI, MATSUMOTO, YOSHINARI, YASUI, TOMOYO, ISHIKO, OSAMU
Publicado 2013

A retrospective clinical analysis of 5 cases of vaginal melanoma

por Tasaka, Reiko, Fukuda, Takeshi, Wada, Takuma, Kawanishi, Masaru, Imai, Kenji, Kasai, Mari, Hashiguchi, Yasunori, Ichimura, Tomoyuki, Yasui, Tomoyo, Sumi, Toshiyuki
Publicado en Mol Clin Oncol (2017)

Extragastrointestinal stromal tumor originating from the vulva

por Fukuda, Takeshi, Sumi, Toshiyuki, Nakano, Yusuke, Morishita, Masanari, Nobeyama, Hiroyuki, Yoshida, Hiroyuki, Matsumoto, Yoshinari, Yasui, Tomoyo, Honda, Ken-ichi, Ishiko, Osamu
Publicado 2011

Pharmacokinetic analyses of carboplatin in a patient with cancer of the fallopian tubes undergoing hemodialysis: A case report

por Wada, Takuma, Fukuda, Takeshi, Kawanishi, Masaru, Tasaka, Reiko, Imai, Kenji, Yamauchi, Makoto, Kasai, Mari, Hashiguchi, Yasunori, Ichimura, Tomoyuki, Yasui, Tomoyo, Sumi, Toshiyuki
Publicado en Biomed Rep (2016)

Age-related differences in prognosis and prognostic factors among patients with epithelial ovarian cancer

por Yoshikawa, Kenji, Fukuda, Takeshi, Uemura, Ryo, Matsubara, Hiroaki, Wada, Takuma, Kawanishi, Masaru, Tasaka, Reiko, Kasai, Mari, Hashiguchi, Yasunori, Ichimura, Tomoyuki, Yasui, Tomoyo, Sumi, Toshiyuki
Publicado en Mol Clin Oncol (2018)